Logo Image

Shorts

CMSC 2026: Aging and Treatment Strategies in MS
1:07
CMSC 2026: Aging and Treatment Strategies in MS
a day ago
by
Amy Gutierrez, MD, FAAN(+1 more)
RECAP: Neurology News Network - June 6th
1:52
RECAP: Neurology News Network - June 6th
2 days ago
by
Louie Pasculli
ATMRD 2026 Session Spotlight: Experiencing Parkinson Speech Therapy Firsthand
1:34
ATMRD 2026 Session Spotlight: Experiencing Parkinson Speech Therapy Firsthand
3 days ago
by
Anissa Mitchell, LCSW(+1 more)
Call to Action: Why Clinicians Should Explore ISSCR's New Stem Cell Course
0:35
Call to Action: Why Clinicians Should Explore ISSCR's New Stem Cell Course
4 days ago
by
Claire Henchcliffe, MD, DPhil
How Stem Cells Differ From Levodopa
2:27
How Stem Cells Differ From Levodopa
4 days ago
by
Claire Henchcliffe, MD, DPhil
The Science Behind Cell Replacement
1:25
The Science Behind Cell Replacement
5 days ago
by
Roger A. Barker, MD, PhD
CMSC 2026: Cognitive Screening in Multiple Sclerosis
1:25
CMSC 2026: Cognitive Screening in Multiple Sclerosis
5 days ago
by
Elizabeth S. Gromisch, PhD(+1 more)
How to Counsel Patients on Emerging Stem Cell Treatments
1:27
How to Counsel Patients on Emerging Stem Cell Treatments
6 days ago
by
Claire Henchcliffe, MD, DPhil
The Case for Expanding MS Clinical Trial Eligibility
0:41
The Case for Expanding MS Clinical Trial Eligibility
6 days ago
by
Jacqueline Nicholas, MD, MPH(+1 more)
Overviewing ISSCR's New Course on Parkinson Disease and Stem Cell Medicine
0:46
Overviewing ISSCR's New Course on Parkinson Disease and Stem Cell Medicine
7 days ago
by
Roger A. Barker, MD, PhD
CMSC 2026: The Patient Journey of Living With MS
1:25
CMSC 2026: The Patient Journey of Living With MS
8 days ago
by
Jamie Lynn Sigler(+1 more)
Are MS Trial Categories Outdated?
0:51
Are MS Trial Categories Outdated?
8 days ago
by
Stephen Krieger, MD(+1 more)
CMSC 2026: Misconceptions on Stopping DMTs in Multiple Sclerosis
1:25
CMSC 2026: Misconceptions on Stopping DMTs in Multiple Sclerosis
8 days ago
by
John Corboy, MD(+1 more)
CMSC 2026: 3 Myths About Pregnancies and MS
1:13
CMSC 2026: 3 Myths About Pregnancies and MS
9 days ago
by
Kristen Krysko, MD(+1 more)
Rethinking the MS Clinical Trial Process
0:35
Rethinking the MS Clinical Trial Process
11 days ago
by
Cecilia Meza, MA(+1 more)
AMDAPP Series: Overviewing Austedo for Movement Disorders
3:00
AMDAPP Series: Overviewing Austedo for Movement Disorders
11 days ago
by
Marco Meglio(+1 more)
CMSC 2026: OCT in the 2024 McDonald Criteria
1:11
CMSC 2026: OCT in the 2024 McDonald Criteria
12 days ago
by
Rachel Kenney, PhD(+1 more)
Questions Patients Should Ask During Diagnostic Workup for Essential Tremor
1:01
Questions Patients Should Ask During Diagnostic Workup for Essential Tremor
13 days ago
by
Mitzi Joi Williams, MD
Can You Regain Lost Sleep?
0:58
Can You Regain Lost Sleep?
13 days ago
by
Mitzi Joi Williams, MD
High Efficacy Treatment Crucial in MS Care
0:39
High Efficacy Treatment Crucial in MS Care
13 days ago
by
Louie Pasculli(+1 more)
Implementing Zeto One EEG Headset Into Clinical Care Settings
1:22
Implementing Zeto One EEG Headset Into Clinical Care Settings
14 days ago
by
Marco Meglio(+1 more)
RECAP: Neurology News Network - May 23rd
1:16
RECAP: Neurology News Network - May 23rd
15 days ago
by
Louie Pasculli
AMDAPP Series: Clinical Use of Onapgo to Treat Parkinson Disease
0:59
AMDAPP Series: Clinical Use of Onapgo to Treat Parkinson Disease
15 days ago
by
Marco Meglio(+1 more)
How Investigational Tavapadon Changes the Parkinson Disease Treatment Landscape
1:14
How Investigational Tavapadon Changes the Parkinson Disease Treatment Landscape
18 days ago
by
Hubert Fernandez, MD
Acting Tremor vs Rest Tremor
1:01
Acting Tremor vs Rest Tremor
18 days ago
by
Mitzi Joi Williams, MD
AMDAPP Series: Understanding Vyalev Pump Therapy for Parkinson Disease
0:59
AMDAPP Series: Understanding Vyalev Pump Therapy for Parkinson Disease
18 days ago
by
Marco Meglio(+1 more)
AAN 2026: Using OCT in Pediatric Multiple Sclerosis
1:21
AAN 2026: Using OCT in Pediatric Multiple Sclerosis
19 days ago
by
Scott Grossman, MD(+1 more)
Overviewing 3-Year Data of Huntington Agent AMT-130
1:32
Overviewing 3-Year Data of Huntington Agent AMT-130
20 days ago
by
Marco Meglio(+1 more)
Clinical Red Flags Prompting Early Evaluation for CNS Involvement in Cancer Patients
1:32
Clinical Red Flags Prompting Early Evaluation for CNS Involvement in Cancer Patients
21 days ago
by
Maya Hrachova, DO(+1 more)
AAN 2026: Phase 3 NIMBLE Study of Cemdisiran in MG
1:31
AAN 2026: Phase 3 NIMBLE Study of Cemdisiran in MG
22 days ago
by
Tuan Vu, MD(+1 more)